Phase 2 Cardiotoxicity Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study of Blood Pressure Control During Cancer Treatment
Breast CancerCardiotoxicity
Memorial Sloan Kettering Cancer Center130 enrolled7 locationsNCT06023576
Recruiting
Phase 2
Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Breast CancerDoxorubicin Induced Cardiotoxicity
Tanta University46 enrolled1 locationNCT07137793
Recruiting
Phase 1Phase 2
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Anthracycline Related Cardiotoxicity in Breast Cancer
Texas Tech University Health Sciences Center70 enrolled1 locationNCT03934905
Recruiting
Phase 2
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Breast CancerHeart FailureMetastatic Breast Cancer+2 more
University Hospital, Akershus60 enrolled1 locationNCT05732051